Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as noted in the metadata request) on January 5, 2016. The report announces consolidated financial results for the second quarter of fiscal year 2016, ended November 29, 2015.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not disclose specific material changes versus the prior comparable period. It serves solely as a notification that financial results for the quarter ended November 29, 2015, have been issued.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. The report explicitly states that the information is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation, not Lifecore Biomedical, Inc.
- Review Exhibit 99.1 (Press Release dated January 5, 2016) for actual financial figures.
- Confirm the fiscal quarter end date of November 29, 2015.
- Note that this 8-K is a notification of results rather than a detailed financial statement.